More than 4,000 clinical urine specimens were evaluated with an automated microbial detection/identification system compared to a standardized manual analysis and the routine modalities used in five peer-group laboratories. The comparison indicates that the automated system recognizes the nine groups of significant microorganisms in urinary tract infections in hospitalized patients with the same efficiency as a standardized manual method. The automated system's ability to enumerate the bacterial populations in the original clinical specimen attained a high degree of accuracy.
Earlier papers (1-4) have described in detail the design and function of the Auto Microbic System (AMS, Vitek Systems, Inc.), its approach to clinical microbiology, and its initial performance in several laboratories with seeded, simulated specimens which challenged the urine Identi-Pak, the first available test procedure which permits an automated system to address a clinical specimen. This report summarizes the experiences of five clinical laboratories in which clinical urine specimens were analyzed by the AMS, the routine procedures of each laboratory, and an agreed-upon standardized manual method.
(Results of work reported here were presented in part at the 78th Annual Meeting of the American Society for Microbiology, Las Vegas, Nevada, 1978.) 
MATERIALS AND METHODS
The participating laboratories included the clinical microbiology laboratories of the Mayo Clinic, Rochester, Minnesota; the Cleveland Clinic Foundation, Cleveland, Ohio; the Jewish Hospital of St. Louis, St. Louis, Mo.; the Long Island Jewish-Hillside Medical Center, New Hyde Park, N.Y., and St. Mary of Nazareth Hospital, Chicago, Ill. The introduction of specimens into the instrument and the methods for evaluating numbers and establishing the generic and species groups for the protista most frequently encountered in urine specimens of patients have been described in detail previously (1, 3, 4) .
All clinical urine specimens received in each laboratory for routine microbiological analysis were introduced into the AMS in the same manner as previously described (3) . The specimens were evaluated by the same manual procedure in all of the laboratories as reported earlier (3) .
Briefly, these methods consisted of introducing 200 /4 into the first compartment of the specimen injector. A second 5-,ld amount of the urine specimen was introduced into the second compartment. The volumes were diluted automatically with 0.5% NaCl and introduced through an evacuation step into the actual specimen cards (Identi-Pak). The latter were then introduced into the instrument for incubation and scanning. The agreed-upon ("standard") evaluation of the urine specimen consisted of seeding 0.1 ml of 1:100 and 1:1,000 dilutions of the urine specimen on two blood agar plates and one MacConkey agar plate. After incubation, enumeration and further identifications were carried out. The two dilutions tested corresponded to 1:1,000 and 1:10,000 dilutions of the original urine. In addition, each laboratory analyzed each specimen in accordance with the procedures used routinely in that respective laboratory. Table 2 shows the performance of the prototype AMS in the peer group laboratories. Specificity ranged from 94 to 99% for 4,184 clinical urine samples. Sensitivity, on the other hand, did not achieve similar levels, prmnarily because of the aforementioned problem with the formation of bubbles in the wells. Pseudomonas detection was only 75%; staphylococci were recovered at a 82% level, the Klebsiella-Enterobacter group and Serratia marcescens at 87%, yeast at 88%, Citrobacter freundlii at 89%, and the remaining bacteria at 94%.
The introduction of the scanner (Table 3) a Standard manual evaluation served as control. Sensitivity and specificity are as defined in the footnote of Table 2 . Of 1,773 specimens, distinct and different from specimens described in Table 2 , 829 had positive results and 304 had negative results. A total of 640 specimens (36%) yielded organisms in numbers ,>70,000 CFU/ml by the standard method and AMS. The standard method detected microorganisms in numbers <70,000 CFU/ml in 569 (32%) additional specimens; the AMS detected numbers <70,000 CFU/ ml in 829 (47%) additional specimens.
'Now improved by adjustments of enrichment milieu. ipating laboratories. As mentioned above, the use of the scanner-improved AMS avoids this problem entirely.
The ability of the prototype AMS to enumerate the microbial densities in clinical urine samples exceeded 90% in this trial. The five wells separately inoculated from the injector reservoir receiving 5 ,l of the original specimen provided an acceptable account of the colony-forming units (CFU) in the original specimen, i.e., more than or less than 70,000 CFU/ml.
DISCUSSION
The studies with clinical specimens indicate that the AMS evaluates actual clinical specimens with the same accuracy manifested with seeded specimens (3) . The instrument is capable of recognizing with efficiency the most important and most common microorganisms isolated from urinary tract infections encountered in patients. The instrument is capable of performing these tasks with a minimum of intervention by technical personnel and it reports the findings with an acceptable accuracy. Since the operator has the capability of requesting the machine to report ad lib, the time to detect a significant microbial organism in any one urine specimen is limited only by the initial number and the sensitivity threshold incorporated in the software of the instrumentation. However, the total incubation of 13 h is required to conclude that a culture is negative. Furthermore, the instrument provides the opportunity to confirm the identification of each of the organisms as well as the chance to submit the organisms within the wells of the card to further biochemical or biological testing. This task can be performed easily with a 10-M1 pipette. Several studies reported by Isenberg et al. at utilized this mode of entry to establish antibiotic susceptibility profiles for Escherichia coli. They indicated ease of performance and the capability of further analysis by either manual or automated methodologies. The early experience with the bubbles led to an improved addition to the detecting mechanisms of the device. Whereas the presence of such physical expressions of filling are dependent in part on the efficacy of the vacuum system supplied in the filling station, it is significant that by the introduction of a scanning detector the automated system acquired the capability to differentiate between the artificially accumulating air bubbles and the turbidity and color changes produced by the presence of microbial particles in specific wells.
Initially, it was thought that this multilaboratory collaborative investigation would provide the opportunity to compare the routine microbiological analysis of urine performed in each laboratory with the method which served as the manual standard for AMS performance. The latter approach used materials produced at a single source and analyzed several dilutions of each specimen in a prescribed fashion followed by each participant (3) . Any microorganism isolated in any dilution was identified and reported, i.e., no judgment concerning the clinical finding was exercised. On the other hand, the routine methods of each laboratory were constrained by guidelines such as the significant number of CFU leading to further studies, the acceptability of a specimen yielding more than two microbial species, classification of specimens on the basis of CFU/ml, the identity of the microorganism isolated, and the available history of patients. These judgmental considerations made a meaningful comparison between the two manual modalities impossible. By far, the most frequent difference arose when the routine clinical approach did not pursue identification of an isolated protist further because it was present in the specimen in numbers less than the accepted criterion. This appeared as a negative result when compared to the standard manual method, which identified all organisms regardless of number in accordance with its expressed purpose as a manual control of the enumerating and recognition functions of the AMS.
It must be emphasized as well that the ability of the instrument to categorize the microorganisms in a specimen is independent of the number of particles established by the nonspecific enumeration wells. The latter is a 1:10 dilution of the inoculum introduced into the differentiating wells. The ability of each organism to grow in its specific compartment is influenced, of course, by the original number present and the time allowed to reach a preset threshold by multiplication. Thus, counts indicating a microbial load of less than 70,000 do not interfere with the ability of the instrument to report the presence of certain bacteria within a specimen. It must also be kept in mind that the time/CFU ratio is different for each well. The enrichmentselective media employed do not permit the same number of multiplications for each organism in its specific well in the same time interval. Thus, the time report does not necessarily indicate the number of particles present. Instead, final counts in the enumeration wells must be taken into consideration. This lack of distinguishing between component microorganisms in a polymicrobic specimen may represent a limitation of the AMS in its present configuration. Studies now in progress are designed to alleviate this problem.
In a previous study (3) , the ability of other organisms to grow and manifest within the urine Identi-Pak has been evaluated. Organisms rarely encountered in clinical urine specimens do not proliferate in the enrichment-selective compartments for specific organisms. The growth control medium, provided in a specific compartment within the card and identical to the medium employed in the enumeration wells, will permit the growth of organisms other than those specifically separated in the AMS. The AMS reports the presence of such organisms as an unidentified microorganism. Aspiration of the growth control well contents and analysis by manual techniques can be used for their identification.
The AMS is the first automated procedure which addresses clinical specimens directly (2); it detects, enumerates, and identifies the most frequent and significant bacteria and yeasts commonly found in urine in a fully automated mode. Heretofore, instrumentation has, for the most part, provided a mechanized approach to the postisolation functions of the clinical microbiology laboratory. Whereas the AMS procedures described so far apply only to 
